Lucigen Corp. enters global licensing agreement
Lucigen Corp. has entered into an agreement that gives it the exclusive, worldwide right to manufacture and sell certain bacterial cells for toxic protein expression. Lucigen, which recently spun off a new company to develop enzymes that increase yields in bioethanol production, sees the cell...